JP2023528804A5 - - Google Patents
Info
- Publication number
- JP2023528804A5 JP2023528804A5 JP2022573211A JP2022573211A JP2023528804A5 JP 2023528804 A5 JP2023528804 A5 JP 2023528804A5 JP 2022573211 A JP2022573211 A JP 2022573211A JP 2022573211 A JP2022573211 A JP 2022573211A JP 2023528804 A5 JP2023528804 A5 JP 2023528804A5
- Authority
- JP
- Japan
- Prior art keywords
- sars
- cov
- phorbol
- pharmaceutical composition
- tpa
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063031551P | 2020-05-28 | 2020-05-28 | |
| US63/031,551 | 2020-05-28 | ||
| PCT/US2021/034494 WO2021243007A2 (en) | 2020-05-28 | 2021-05-27 | Compositions and methods for treating acute respiratory distress syndrome (ards) and inflammatory disorders caused by coronaviruses and other respiratory pathogens or agents that mediate pulmonary injury, inflammation or acute respiratory distress, and related compositions and methods for treating and preventing human sars coronavirus infection, covid-19 disease and related symptoms |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023528804A JP2023528804A (ja) | 2023-07-06 |
| JP2023528804A5 true JP2023528804A5 (cg-RX-API-DMAC7.html) | 2025-02-20 |
Family
ID=78722786
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022573211A Pending JP2023528804A (ja) | 2020-05-28 | 2021-05-27 | コロナウイルスが引き起こす急性呼吸窮迫症候群(ards)および炎症性障害を処置するための組成物および方法 |
Country Status (12)
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113444177A (zh) * | 2020-03-27 | 2021-09-28 | 中山康方生物医药有限公司 | 抗IL-1β的抗体、其药物组合物及其用途 |
| WO2021207497A1 (en) * | 2020-04-08 | 2021-10-14 | Arizona Board Of Regents On Behalf Of Arizona State University | Covid-19 inflammatory cytokine storm treatment |
| US20230071393A1 (en) * | 2020-04-16 | 2023-03-09 | University Of Pittsburgh - Of The Commonwealth System Of Higher Education | Matrix bound vesicles (mbv) for treatment of acute respiratory distress syndrome |
| US11402391B2 (en) | 2020-12-21 | 2022-08-02 | Incelldx, Inc. | Methods of treating a long-hauler subject for chronic COVID-19 by administering a CCR5 or CCL5 antagonist |
| CN115252760B (zh) * | 2022-03-30 | 2024-05-31 | 厦门大学 | 一种广谱抗冠状病毒的制剂及其制备方法 |
| WO2025029797A1 (en) * | 2023-08-01 | 2025-02-06 | Incelldx, Inc. | Methods of assigning a covid pathological type and compositions for practicing the same, and methods of treating a subject for chronic covid-19 |
| CN117304031A (zh) * | 2023-09-05 | 2023-12-29 | 深圳大学 | 一种铁苋菜二萜类化合物、铁苋菜提取物及其在制备具有抗氧化和/或抗炎作用的产品中的应用 |
| CN117414438B (zh) * | 2023-11-01 | 2025-10-17 | 大连医科大学附属第一医院 | 一种靶向m1型巨噬细胞的多肽偶联药物及其应用 |
| CN117919385B (zh) * | 2024-02-05 | 2024-10-18 | 中国医学科学院医学实验动物研究所 | IL-37在MERS-CoV感染疾病的治疗中的应用 |
| CN121490288A (zh) * | 2025-11-21 | 2026-02-10 | 中山大学附属第三医院 | 一种用于急性呼吸窘迫综合征的肺部交感神经局部光遗传激活系统及方法 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AUPP223198A0 (en) * | 1998-03-06 | 1998-04-02 | Fujisawa Pharmaceutical Co., Ltd. | New use |
| US20030109486A1 (en) * | 2001-10-31 | 2003-06-12 | Eliezer Rapaport | Methods and therapeutic compositions for utilization of adenosine 5'-triphosphate (ATP) in the treatment of acute lung injury (ALI) and acute respiratory distress syndrome (ARDS) |
| ES2464459T3 (es) * | 2008-06-25 | 2014-06-02 | H. Lundbeck A/S | Modulación del sistema receptor Trpv:receptor de dominio Vps 10p para el tratamiento del dolor |
| WO2010036945A2 (en) * | 2008-09-26 | 2010-04-01 | The Regents Of The University Of Michigan | Nanoemulsion therapeutic compositions and methods of using the same |
| US20130203715A1 (en) * | 2010-07-20 | 2013-08-08 | Pulmatrix, Inc. | Use of trp channel agonists to treat infections |
| KR101374760B1 (ko) * | 2011-10-26 | 2014-03-17 | 한국생명공학연구원 | 포볼 타입의 디테르펜 화합물 및 이를 포함하는 바이러스 감염 질환의 치료 또는 예방용 약학적 조성물 |
| JP6977206B2 (ja) * | 2016-03-31 | 2021-12-08 | 富山県 | 自然免疫を活性化する粘膜ワクチン用アジュバント |
| WO2019108456A1 (en) * | 2017-12-01 | 2019-06-06 | Children's Hospital Medical Center | Compositions for interferon blockade and methods of using same |
-
2021
- 2021-05-27 CN CN202180059368.3A patent/CN117015375A/zh active Pending
- 2021-05-27 WO PCT/US2021/034494 patent/WO2021243007A2/en not_active Ceased
- 2021-05-27 AU AU2021281257A patent/AU2021281257A1/en not_active Abandoned
- 2021-05-27 CA CA3180577A patent/CA3180577A1/en active Pending
- 2021-05-27 JP JP2022573211A patent/JP2023528804A/ja active Pending
- 2021-05-27 EP EP21812442.8A patent/EP4304570A4/en active Pending
- 2021-05-27 BR BR112022024226A patent/BR112022024226A2/pt not_active Application Discontinuation
- 2021-05-27 US US17/928,235 patent/US20230248684A1/en not_active Abandoned
- 2021-05-27 KR KR1020227045667A patent/KR20230058014A/ko active Pending
- 2021-05-27 MX MX2022014958A patent/MX2022014958A/es unknown
- 2021-05-27 IL IL298593A patent/IL298593B1/en unknown
-
2022
- 2022-11-28 CL CL2022003348A patent/CL2022003348A1/es unknown
-
2023
- 2023-11-10 US US18/388,597 patent/US20240082202A1/en not_active Abandoned
-
2025
- 2025-10-17 US US19/362,286 patent/US20260041660A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Amirian et al. | Current knowledge about the antivirals remdesivir (GS-5734) and GS-441524 as therapeutic options for coronaviruses | |
| Diez-Porras et al. | Guillain-Barré-Strohl syndrome and COVID-19: case report and literature review | |
| US20220088403A1 (en) | Methods And Compositions For Treating Coronavirus | |
| EA035439B1 (ru) | Амидное соединение и его применение в качестве средства для лечения и профилактики заболеваний, вызываемых рнк- и/или днк-содержащими вирусами, и сопутствующих заболеваний | |
| RU2008145510A (ru) | Композиции и способы диагностики и лечения астмы или других аллергических или воспалительных заболеваний | |
| Pagliano et al. | Is Hydroxychloroquine a possible postexposure prophylaxis drug to limit the transmission to healthcare workers exposed to coronavirus disease 2019? | |
| WO2019033122A1 (en) | TREATMENT OF PULMONARY DISEASES USING PHARMACEUTICAL AGENTS THAT ELIMINATE SENESCENT CELLS | |
| Zhang et al. | Novel derivatives of brincidofovir and (S)-9-(3-hydroxy-2-phosphonylmethoxypropyl) adenine inhibit orthopoxviruses and human adenoviruses more potently than brincidofovir | |
| JP2023535518A (ja) | SARS-CoV-2及び他の病原性ウイルスの複製を遮断するためのWNT/β-カテニン経路阻害薬の使用 | |
| WO2021207155A1 (en) | Airway epithelial alkaline therapy to treat viral respiratory infection | |
| WO2021169984A1 (zh) | 聚adp核糖聚合酶抑制剂在抗冠状病毒中的应用 | |
| Zhang et al. | Modulating apoptosis as a novel therapeutic strategy against respiratory syncytial virus infection: insights from rotenone | |
| US11433080B2 (en) | Antiviral treatment | |
| JP7346710B2 (ja) | 新型コロナウイルス感染症の予防又は治療用医薬組成物 | |
| US12329727B2 (en) | Use of salmeterol as an anti-coronaviral agent | |
| WO2021255226A1 (en) | Antiviral use of calixarenes | |
| Kaushik et al. | Glycolytic stress deteriorates 229E virulence to improve host defense response | |
| CN117320748A (zh) | Covid-19进入抑制剂对covid-19复制的遏制 | |
| EP4132518B1 (en) | Dantrolene for use in methods of treating sars-cov-2 infections | |
| Altay et al. | Post-COVID-19 extensive maxillary actinomycotic osteonecrosis: A rare case report | |
| CN115916189A (zh) | 治疗严重急性呼吸综合征的方法 | |
| HK40083259B (en) | Dantrolene for use in methods of treating sars-cov-2 infections | |
| IT202300022647A1 (it) | Uso di elysivir per il trattamento della malattia da coronavirus 2019 (covid-19) | |
| HK40090314A (zh) | 治疗严重急性呼吸综合征的方法 | |
| HK40104268A (en) | Anti-viral agent |